Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.1407
-0.0048 (-3.30%)
At close: Sep 25, 2026, 4:00 PM EDT
0.1391
-0.0016 (-1.14%)
After-hours: Sep 25, 2026, 7:43 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $2.83 million as of September 25, 2026. Its market cap has decreased by -89.16% in one year.
Market Cap
2.83M
Enterprise Value
13.56M
1-Year Change
-89.16%
Ranking
Category
Stock Price
$0.14
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $2.83M, a decrease of -97.27%. That is a compound annual growth rate of -46.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 2.83M | -84.49% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| INVO Fertility | 4.51M |
| Aethlon Medical | 4.47M |
| Adagio Medical Holdings | 4.33M |
| Bluejay Diagnostics | 4.12M |
| Autonomix Medical | 3.90M |
| VolitionRx | 3.68M |
| Nexalin Technology | 3.22M |
| Nuwellis | 2.83M |